By
Christina Roman
July 22, 2015
The CF Foundation is focused on bringing forward new
therapies to help people with CF enjoy the best health and quality of life.
Following the approval of the new CF drug Orkambi, we sat down with Dr. Mike
Boyle, our new vice president of therapeutics development, to learn more about
the future of clinical research and what’s most exciting.